Tags

Type your tag names separated by a space and hit enter

Evaluation of two dextrose-based directly compressible excipients.
Drug Dev Ind Pharm. 1998 Aug; 24(8):771-8.DD

Abstract

The objectives of this research were to evaluate the physical properties and compaction behavior of two dextrose-based directly compressed excipients. Anhydrous theophylline (10% w/w) was used as a drug model, Emdex and or Maltrin M510 (89.5% w/w) were used as diluent, and magnesium stearate (0.5% w/w) was used as lubricant. Direct compression and wet granulation methods were used for preparing the compacts. In general, the wet granulation method reduced the density of the mixture and consequently its flow rate compared to the mixture prepared only by solid-solid mixing. All formulations were compressed at four different compressional forces and at a target weight of 450 mg +/- 5%. Tablets obtained were different in physical properties and mechanical strength based on type of excipient used and methods of tablet preparation (direct compression versus wet granulation). Compacts prepared from Maltrin M510 had a longer disintegration time and slower drug release than compacts of the same composition but prepared with Emdex. Disintegration time and drug dissolution from tablets containing Maltrin M510 as diluent and prepared by wet granulation appeared to be controlled by a "gel" layer formation around the tablets and not by the tablets porosity. This study demonstrates that full characterization of excipients is needed because a different manufacturing process for the same excipients may produce differences in the pharmaceutical products.

Authors+Show Affiliations

School of Pharmacy, University of Puerto Rico, San Juan 00936-5067, USA.No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9876525

Citation

Olmo, I G., and E S. Ghaly. "Evaluation of Two Dextrose-based Directly Compressible Excipients." Drug Development and Industrial Pharmacy, vol. 24, no. 8, 1998, pp. 771-8.
Olmo IG, Ghaly ES. Evaluation of two dextrose-based directly compressible excipients. Drug Dev Ind Pharm. 1998;24(8):771-8.
Olmo, I. G., & Ghaly, E. S. (1998). Evaluation of two dextrose-based directly compressible excipients. Drug Development and Industrial Pharmacy, 24(8), 771-8.
Olmo IG, Ghaly ES. Evaluation of Two Dextrose-based Directly Compressible Excipients. Drug Dev Ind Pharm. 1998;24(8):771-8. PubMed PMID: 9876525.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Evaluation of two dextrose-based directly compressible excipients. AU - Olmo,I G, AU - Ghaly,E S, PY - 1999/1/7/pubmed PY - 1999/1/7/medline PY - 1999/1/7/entrez SP - 771 EP - 8 JF - Drug development and industrial pharmacy JO - Drug Dev Ind Pharm VL - 24 IS - 8 N2 - The objectives of this research were to evaluate the physical properties and compaction behavior of two dextrose-based directly compressed excipients. Anhydrous theophylline (10% w/w) was used as a drug model, Emdex and or Maltrin M510 (89.5% w/w) were used as diluent, and magnesium stearate (0.5% w/w) was used as lubricant. Direct compression and wet granulation methods were used for preparing the compacts. In general, the wet granulation method reduced the density of the mixture and consequently its flow rate compared to the mixture prepared only by solid-solid mixing. All formulations were compressed at four different compressional forces and at a target weight of 450 mg +/- 5%. Tablets obtained were different in physical properties and mechanical strength based on type of excipient used and methods of tablet preparation (direct compression versus wet granulation). Compacts prepared from Maltrin M510 had a longer disintegration time and slower drug release than compacts of the same composition but prepared with Emdex. Disintegration time and drug dissolution from tablets containing Maltrin M510 as diluent and prepared by wet granulation appeared to be controlled by a "gel" layer formation around the tablets and not by the tablets porosity. This study demonstrates that full characterization of excipients is needed because a different manufacturing process for the same excipients may produce differences in the pharmaceutical products. SN - 0363-9045 UR - https://www.unboundmedicine.com/medline/citation/9876525/Evaluation_of_two_dextrose_based_directly_compressible_excipients_ L2 - https://www.tandfonline.com/doi/full/10.3109/03639049809082725 DB - PRIME DP - Unbound Medicine ER -